US Bancorp’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,702
| Closed | -$115K | – | 3811 |
|
|
2019
Q3 | $115K | Sell |
1,702
-95
| -5% | -$6.52K | ﹤0.01% | 2088 |
|
|
2019
Q2 | $105K | Sell |
1,797
-1,336
| -43% | -$79.1K | ﹤0.01% | 2187 |
|
|
2019
Q1 | $219K | Buy |
3,133
+793
| +34% | +$58.8K | ﹤0.01% | 1770 |
|
|
2018
Q4 | $151K | Buy |
2,340
+71
| +3% | +$4.98K | ﹤0.01% | 1907 |
|
|
2018
Q3 | $159K | Buy |
2,269
+272
| +14% | +$15.9K | ﹤0.01% | 1981 |
|
|
2018
Q2 | $101K | Buy |
1,997
+386
| +24% | +$15.3K | ﹤0.01% | 2246 |
|
|
2018
Q1 | $51K | Sell |
1,611
-2,711
| -63% | -$89.9K | ﹤0.01% | 2610 |
|
|
2017
Q4 | $148K | Buy |
4,322
+784
| +22% | +$25K | ﹤0.01% | 2053 |
|
|
2017
Q3 | $114K | Buy |
3,538
+508
| +17% | +$16K | ﹤0.01% | 2159 |
|
|
2017
Q2 | $98K | Buy |
3,030
+415
| +16% | +$13.1K | ﹤0.01% | 2203 |
|
|
2017
Q1 | $82K | Buy |
2,615
+1,401
| +115% | +$41.4K | ﹤0.01% | 2244 |
|
|
2016
Q4 | $36K | Buy |
1,214
+960
| +378% | +$29.3K | ﹤0.01% | 2607 |
|
|
2016
Q3 | $7K | Buy |
254
+47
| +23% | +$1.31K | ﹤0.01% | 3099 |
|
|
2016
Q2 | $5K | Hold |
207
| – | – | ﹤0.01% | 3208 |
|
|
2016
Q1 | $5K | Buy |
+207
| New | +$5.68K | ﹤0.01% | 3188 |
|
|
2015
Q3 | – | Sell |
-503
| Closed | -$14K | – | 3724 |
|
|
2015
Q2 | $14K | Hold |
503
| – | – | ﹤0.01% | 3053 |
|
|
2015
Q1 | $15K | Hold |
503
| – | – | ﹤0.01% | 3033 |
|
|
2014
Q4 | $16K | Sell |
503
-1,347
| -73% | -$43.8K | ﹤0.01% | 2972 |
|
|
2014
Q3 | $52K | Sell |
1,850
-1,925
| -51% | -$53.7K | ﹤0.01% | 2475 |
|
|
2014
Q2 | $103K | Buy |
3,775
+105
| +3% | +$2.79K | ﹤0.01% | 2117 |
|
|
2014
Q1 | $97K | Sell |
3,670
-1,553
| -30% | -$44.6K | ﹤0.01% | 2134 |
|
|
2013
Q4 | $153K | Sell |
5,223
-1,156
| -18% | -$36.7K | ﹤0.01% | 1870 |
|
|
2013
Q3 | $195K | Sell |
6,379
-23
| -0.4% | -$769 | ﹤0.01% | 1700 |
|
|
2013
Q2 | $203K | Buy |
+6,402
| New | +$210K | ﹤0.01% | 1635 |
|
US Bancorp's GHDX Position: Q4 2019 in Review
US Bancorp sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 1,702 shares — an estimated $115K sold.
US Bancorp first reported a position in GHDX in Q2 2013 and held it in 24 quarters. The position peaked at $219K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- US Bancorp reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- US Bancorp sold 1,702 Genomic Health, Inc. shares in Q4 2019, an estimated $115K.
- US Bancorp first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 24 quarters.
- US Bancorp's Genomic Health, Inc. position peaked at $219K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.